Skip to main content
. 2015 Sep 18;59(10):6188–6194. doi: 10.1128/AAC.00718-15

FIG 2.

FIG 2

Simulated versus observed proportion of subjects receiving tafenoquine for determining relapse-free status at 6 months (logistic regression analysis).